Kidswell Bio Corp (4584) Stock Price & News

4584:TYO

Kidswell Bio Corp

¥154.00

-0.65%

(-1.00) 1D

Oct 29, 3:30:00 PM GMT+9 · JPY

All symbols

	Symbol	Price	Change	% Change

Generating top insights for 4584...

Open

¥154

High

¥154

Low

¥150

Mkt. cap

7.79B

Avg. vol.

228.22K

Volume

214.10K

52-wk high

¥320

52-wk low

¥125

EPS

-¥8

Shares outstanding

19.68M

No. of employees

Open

¥154

High

¥154

Low

¥150

Mkt. cap

7.79B

Avg. vol.

228.22K

Volume

214.10K

52-wk high

¥320

52-wk low

¥125

EPS

-¥8

Shares outstanding

19.68M

No. of employees

Related stocks

Chiome Bioscience Inc

¥92.00

-1.08%

4594

BrightPath Biotherapeutics Co Ltd

¥41.00

0.00%

News stories

From web sources and news partners

CryptoPotato

1 hour ago

HYPE Price Rises 15% Following NYSE Plan to Bring Hyperliquid Perps to the US

Seeking Alpha

14 minutes ago

VIX continues to drop, but so do hyperscalers

Yahoo Finance

38 minutes ago

Prediction: This Magnificent ETF Will Crush the S&P 500 Over the Next 10 Years

CNBC

5 hours ago

Alphabet drags on Nasdaq futures as the stock faces a record post-earnings loss

About Kidswell Bio Corp

CEOMasaharu Tani

Employees32

FoundedMar 1, 2001

Headquarters-

SectorBiotechnology

Websitekidswellbio.com

All values in JPY	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	1.56B	1.74B	1.57B	1.27B
Cost of goods sold	1.16B	1.41B	1.38B	839.00M
Cost of revenue	1.16B	1.41B	1.38B	839.00M
Research and development expenses	175.92M	282.64M	448.00M	32.00M
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	188.51M	185.85M	-31.91M	182.00M
Operating expense	364.43M	468.50M	416.09M	214.00M
Total operating expenses	1.52B	1.87B	1.79B	1.05B
Operating income	31.35M	-131.26M	-223.08M	216.00M
Other non operating income	-1.11M	-120.18M	53.56M	3.00M
EBT including unusual items	-89.62M	-211.59M	-277.69M	236.00M
EBT excluding unusual items	24.38M	-336.86M	-115.08M	203.00M
Income tax expense	7.51M	-8.20M	-7.49M	39.00M
Effective tax rate	-8.38%	3.88%	2.70%	16.53%
Other operating expenses	-	-	-	-
Net income	-97.13M	-203.38M	-270.20M	197.00M
Net profit margin	-6.24%	-11.67%	-17.21%	15.52%
Earnings per share	-	-	-	-
Interest and investment income	2.00M	-	2.47M	-
Interest expense	-7.45M	-10.19M	-21.03M	-23.00M
Net interest expenses	-5.45M	-10.19M	-18.56M	-23.00M
Depreciation and amortization charges	-	-	-	-
EBITDA	-	-	-223.02M	216.06M
Gain or loss from assets sale	-	-	-	-

Ask anything